Asaoka Tadafumi, Marubashi Shigeru, Dono Keizo, Hama Naoki, Kim Chiwan, Kobayashi Shogo, Takeda Yutaka, Nagano Hiroaki, Umeshita Koji, Monden Morito, Doki Yuichiro, Mori Masaki
Dept. of Surgery, Graduate School of Medicine, Osaka University.
Gan To Kagaku Ryoho. 2008 Nov;35(12):2086-7.
We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.
